C. Marsden

发表

L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP.

C. Marsden, P. Jenner, J. Jolkkonen, 1995, Brain research. Molecular brain research.

Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.

C. Marsden, W. Gibb, P. Jenner, 1993, European journal of pharmacology.

Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

C. Marsden, P. Carrupt, B. Testa, 1995, Neuroreport.

Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

C. Marsden, P. Carrupt, B. Testa, 1995, Biochemical pharmacology.

Oxidative Stress and Parkinson's Disease a

C. Marsden, A. Schapira, A. Schapira, 1996, Annals of the New York Academy of Sciences.

Differential labelling of dopamine receptors in rat brain in vivo: comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine.

C. Marsden, P. Jenner, P. Jenner, 1983, European journal of pharmacology.

Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5‐hydroxytryptamine *

C. Marsden, P. Jenner, P. Jenner, 1975, The Journal of pharmacy and pharmacology.

Cation regulation differentiates specific binding of [3 H]sulpiride and [3 H]spiperone to rat striatal preparations

P. Jenner, P. Jenner, C. Marsden, 1980, The Journal of pharmacy and pharmacology.

A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs

C. Marsden, P. Jenner, A. Clow, 1978, The Journal of pharmacy and pharmacology.

Psychiatric symptoms during L-dopa therapy for Parkinson's disease and their relationship to physical disability

C. Marsden, J. Parkes, R. Mindham, 1976, Psychological Medicine.

Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.

P. Jenner, A. Galea-Debono, C. Marsden, 1977, Journal of neurology, neurosurgery, and psychiatry.

Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset

C. Marsden, A. Hunter, P. Jenner, 1995, Psychopharmacology.

Altered Muscarinic and Nicotinic Receptor Densities in Cortical and Subcortical Brain Regions in Parkinson's Disease

C D Marsden, P. Jenner, K W Lange, 1993, Journal of neurochemistry.

Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

S. Hunt, A. Fine, W. Oertel, 1988, Progress in brain research.